Ticker: CJJD, Company: CHINA JO-JO DRUGSTORES, INC., Type: 10-K, Date: 2017-06-29, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CJJD/20170629/10-K/1/000.htm SEC Original: f10k2017_chinajojodrug.htm
TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED MARCH 31, 2017 Page PART I. Item 1. Business. 1 Item 1A. Risk Factors. 15 Item 1B. Unresolved Staff Comments. 32 Item 2. Properties. 33 Item 3.

---

---

Webplus: CJJD/20170629/10-K/2_EX-10.33/000.htm SEC Original: f10k2017ex10xxxiii_chinajojo.htm
CHINA JO-JO DRUGSTORES, INC. March 29, 2017 Via Email Dear Ms. Wang: Our company compensates our non-employee directors for all services they perform as a director of our company, including attendance at Board of Directors meetings and service as members of committees of the Board of Directors to which they are appointed. You will receive an annual compensation of US$11,896

---

---

Webplus: CJJD/20170629/10-K/3_EX-23.1/000.htm SEC Original: f10k2017ex23i_chinajojo.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM BDO CHINA SHU LUN PAN Certified Public Accountants LLP June 29, 2017 EX-23.1 3 f10k2017ex23i_chinajojo.htm CONSENT OF INDEPENDENT PUBLICLY REGISTERED ACCOUNTING FIRM, BDO CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LLP

---

---

Webplus: CJJD/20170629/10-K/4_EX-31.1/000.htm SEC Original: f10k2017ex31i_chinajojodrug.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: (1) I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: CJJD/20170629/10-K/5_EX-31.2/000.htm SEC Original: f10k2017ex31ii_chinajojodrug.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: (1) I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: CJJD/20170629/10-K/6_EX-32.1/000.htm SEC Original: f10k2017ex32i_chinajojodrug.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 “ ” “ ” (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer Ming Zhao Chief Financial Officer (Principal Financial and

---

Company Info:

Ticker: CJJD, Company: CHINA JO-JO DRUGSTORES, INC., Type: 10-K, Date: 2017-06-29, XBRL Interactive FinancialsCIK: 0001413263, Location: F4, SIC: 2833, SIC Desc: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Business Phone & Address:
1ST FLOOR, YUZHENG PLAZA, YUHUANGSHAN ROAD, HANGZHOU CITY
ZHEJIANG PROVINCE 310008